Patent Grant
7384430
The present disclosure generally relates to low crystalline polymeric material and an associated method of treating a polymeric material. The present disclosure particularly relates to (i) a low crystalline polymeric material for use in orthopaedic devices for implantation in the body of an animal and (ii) a method of treating a polymeric material for use in orthopaedic devices for implantation in the body of an animal.
Implantable prosthetic devices typically include a component constructed from a polymeric material, such as polyethylene. For example, many implantable prosthetic devices include a bearing component, such as an acetabular bearing, a glenoid bearing, or a tibial bearing made from a polymeric material such as Ultra-High Molecular Weight Polyethylene (UHMWPE). UHMWPE is utilized in the construction of prosthetic bearing components due to its favorable mechanical and wear characteristics. Moreover, it has been determined that certain characteristics of polymeric materials, such as UHMWPE, may be enhanced by exposing the material to radiation. For example, exposing UHMWPE to predetermined doses of radiation crosslinks the UHMWPE and thereby increases its wear resistance. Accordingly, many prosthetic devices include a bearing component constructed of crosslinked UHMWPE in order to gain the aforementioned benefits.
However, the irradiation of polymeric materials, like UHMWPE, to increase their wear resistance can also cause the degradation of other mechanical characteristics of the material. For example, the mechanical characteristics which allow a polymer component to appropriately withstand high stress applications, such as those associated with locking rings and tabs, can deteriorate if the polymeric material is exposed to certain amounts of radiation. One approach to this problem is not to use highly crosslinked UHMWPE in high stress designs. For example, in some instances UHMWPE is only exposed to a reduced or low dose of radiation so that it will have adequate mechanical properties to withstand these high stress designs. Therefore, this UHMWPE will only be crosslinked to a low degree. However, a problem with this approach is that the wear rate of this low crosslinked polymeric material tends to be less than optimal. Therefore, a polymeric material and associated method for treating a polymeric material that results in it having an enhanced wear rate and other mechanical properties (e.g. the properties which allow the material to appropriately withstand high stress applications) is desirable.
A method in accordance with an illustrative embodiment of the present disclosure includes one or more of the following features or combinations thereof:
In one embodiment the present disclosure provides a method for treating a polymeric material. The polymeric material can be consolidated into a work piece. For example, the work piece can be in the form of a rod, bar, sheet or molded component. Moreover, polymeric material which is porous or nonporous may be utilized. In another embodiment, the polymeric material can be utilized to fabricate a polymeric bearing component. For example, the polymeric material can be utilized to fabricate a polymeric bearing component of an implantable orthopaedic device, such as a knee, hip, shoulder, or elbow prostheses. Accordingly, the polymeric material can be any medical grade polymeric material which may be implanted into the body of an animal (e.g. the body of a human patient). An example of a polymeric material that can be treated with the method described herein is medical grade polyethylene such as polyethylene homopolymer, high density polyethylene, high molecular weight polyethylene, high density high molecular weight polyethylene, or any other type of polyethylene utilized in the construction of a prosthetic implant. A more specific example of such a polymer is medical grade ultrahigh molecular weight polyethylene (UHMWPE).
In addition, the polymeric material utilized, for example, to fabricate a polymeric bearing component has a crystallinity. For example, initially the crystallinity of the polymeric material can be greater than about 50%, such as a semicrystalline polymeric material. In particular, the initial crystallinity of the polymeric material can be, for example, in the range of from about 50% to about 70%. Even more particular, the initial crystallinity of the polymeric material can be, for example, in the range of from about 50% to about 60%. The method can include changing the crystallinity of the polymeric material from a first crystallinity to a second crystallinity, where the second crystallinity is less than the first crystallinity. In other words, the method can include reducing or decreasing the crystallinity of the polymeric material.
As indicated above, the crystallinity of the polymeric material can be decreased. For example, the crystallinity of the polymeric material, such as UHMWPE, can be decreased to about 50% crystallinity or less (i.e. crystallinity less than 50%). In another example, the crystallinity of the polymeric material can be decreased to within a range of from about 40% crystallinity to about 50% crystallinity. In yet another example, the initial crystallinity of the polymeric material can be decreased by about 5%. In still another example, the initial crystallinity of the polymeric material can be decreased by from about 10% to about 30%.
One way the crystallinity of the polymeric material can be decreased is by heating the polymeric material to a temperature sufficient to decrease its crystallinity. For example, the polymeric material can be heated to about its melt point, or to a temperature above its melt point. Heating the polymeric material in this manner increases the amorphous content of the polymeric material and thus decreases its crystallinity.
After heating the polymeric material to increase its amorphous phase, the polymeric material can be cooled at a rate sufficient to lock in the amorphous phase. For example, the polymeric material can be cooled to a temperature below its melt point to lock in the amorphous phase, and thereby decrease the crystallinity of the polymeric material. The cooling can be accomplished by any method or procedure which results in a cooling rate sufficient to cause an increase in the amorphous phase and thus accomplish a decrease in the crystallinity of the polymeric material. For example, the cooling rate can be in the range of from about 1° C./minute to about 50° C./minute or greater. For example, from about 100° C./minute to about 300° C./minute. The process for cooling the polymeric material can involve any number of cooling media such as liquid nitrogen, alcohol/dry ice, cooled salt water, air, room temperature water, or a cooled surface, such as a metallic surface or a ceramic surface. In addition, cooling gases are also contemplated.
In addition the crystallinity of the polymeric material can be decreased so that a crystallinity gradient is formed in the polymeric material. For example, the polymeric material can be heated to its melt point or to a temperature greater than its melt point and then cooled at a rate sufficient to form a crystallinity gradient in the polymeric material. In one embodiment the crystallinity gradient is positioned such that crystallinity of the polymeric material increases moving in a direction away from the exterior surface of the polymeric material toward an interior location of the polymeric material.
After decreasing the crystallinity of the polymeric material it can be subjected to a crosslinking process. For example, exposing the polymeric material to radiation such as gamma radiation, electron beam, or X-rays will cause the crosslinking of the polymeric material. Such exposure may be in the exemplary range of from about 5 kGy to about 500 kGy, illustratively from about 25 kGy to about 100 kGy, and illustratively from about 30 kGy to about 60 kGy. As indicated above, a specific example of a crosslinked polymeric material that can be utilized in the construction of a device to be implanted in the body of an animal, such as the bearing component described herein, is crosslinked UHMWPE.
After crosslinking the polymeric material it may be subjected to a post-irradiation free radical quenching process. For example, the free radical containing polymeric material can be melt annealed to quench the free radicals. For example, the free radical containing polymeric material can be placed into a vacuum oven under reduced pressure. To quench substantially all the free radicals present in the polymeric material, the temperature of the vacuum oven can then be raised to above the melting point of the polymeric material (e.g. greater than 135° C.) until it is completely melted. The polymeric material can then be kept at a temperature above its melt point for a time period of about 24 hours, or other time period deemed adequate to quench the free radicals. In any event, the polymeric material subjected to a post-irradiation free radical quenching process will be substantially free of free radicals.
As indicated above, a polymeric material subjected to a treatment described herein can be utilized as a polymeric component of an implantable orthopaedic device, for example a bearing component of a knee, hip, shoulder, or elbow prostheses. Accordingly, the polymeric material can be subjected to a sterilization process, such as being gas plasma sterilized or ethylene oxide sterilized, prior to the orthopaedic device being implanted in the body of an animal. However, it should be appreciated that sterilizing the polymeric material and crosslinking the polymeric material can occur simultaneously.
In another embodiment, the present disclosure provides a method of preparing an implantable orthopaedic device that includes a component made from a polymeric material that is treated by a method described herein. Accordingly, the present disclosure also provides an implantable orthopaedic device that includes a component made from a crosslinked polymeric material, wherein the crosslinked polymeric material has a crystallinity of about 50% or less, or has a crystallinity gradient formed therein. For example, the polymeric material having a crystallinity of about 50% or less, or has a crystallinity gradient formed therein can be crosslinked UHMWPE serving as a bearing component in the orthopaedic device.
Additional features of the present disclosure will become apparent to those skilled in the art upon consideration of the following detailed description of preferred embodiments exemplifying the best mode of carrying out the subject matter of the disclosure as presently perceived.
While the invention described herein is susceptible to various modifications and alternative forms, a specific embodiment thereof has been shown by way of example and will herein be described in detail. It should be understood, however, that there is no intent to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention as defined by the appended claims.
An exemplary embodiment of the present invention is directed to a method for treating a polymeric material for use in an implantable orthopaedic device. As previously mentioned the polymeric material can be consolidated into a work piece if desired. For example, the work piece can be in the form of a rod, bar, sheet or molded component. It should also be appreciated that a porous or nonporous material can be utilized. As indicated the work piece can, for example, be made into a polymeric bearing component of an implantable orthopaedic device. What is meant herein by the term “bearing” is an orthopaedic implant prosthetic bearing of any type, condition, shape, or configuration. Such bearings may be utilized in a number of joint replacement or repair procedures, such as surgical procedures associated with the hip, shoulders, knees, ankles, knuckles, or any other joint. For example, a polymeric material subjected to a treatment of the present disclosure can be utilized as an implantable prosthetic bearing such as a glenoid bearing for implantation into a glenoid of a patient, an acetabular bearing for implantation into an acetabulum of a patient, and a tibial bearing for implantation into a tibia of a patient. Each of the prosthetic bearings include an articulating or bearing surface on which a natural or prosthetic component bears. For example, in the case of the glenoid bearing, a natural or prosthetic humeral head bears on the articulating surface. Similarly, in the case of an acetabular bearing, a natural or prosthetic femoral head bears on the articulating surface. Moreover, in the case of the tibial bearing, one or a pair of natural or prosthetic femoral condyles bear on the articulating surface.
The polymeric material which can be utilized in the present invention can be any medical grade polymeric material which may be implanted into the body of an animal (e.g. the body of a human patient). An example of a polymeric material that can be utilized in the present invention includes for example medical grade polyethylene such as polyethylene homopolymer, high density polyethylene, high molecular weight polyethylene, high density high molecular weight polyethylene, or any other type of polyethylene utilized in the construction of an implant. A more specific example of such a polymer is medical grade ultrahigh molecular weight polyethylene (UHMWPE).
The polymeric material utilized to implant into the body of an animal will have an initial crystallinity. In particular, the polymeric material will have a particular crystallinity prior to being subjected to a method described herein. Various polymeric materials have different degrees of crystallinity. For example, as indicated above, initially the crystallinity of the polymeric material utilized in the present invention can about 50% or greater. In particular, the initial crystallinity of the polymeric material utilized can be, for example, in the range of from about 50% to about 70%. Even more particular, the initial crystallinity of the polymeric material can be, for example, in the range from about 50% to about 60%.
In one embodiment of the invention described herein the initial crystallinity of the polymeric material is changed. In particular, the crystallinity of the polymeric material is decreased as compared to its initial crystallinity. In other words, the crystallinity of the polymeric material is changed from a first crystallinity to a second crystallinity, where the second crystallinity is less than the first crystallinity. In one example the crystallinity of the polymeric material is decreased to about 50% crystallinity or less. For example, the crystallinity of the polymeric material can be decreased to within a range of from about 40% crystallinity to about 50% crystallinity.
In yet another example, the initial crystallinity of the polymeric material can be decreased by about 5%. In still another example, the initial crystallinity of the polymeric material can be decreased by about 10% to about 30%. In a specific example the crystallinity of UHMWPE can be decreased to about 50% or less.
It should be appreciated that the crystallinity of the polymeric material can be decreased in any appropriate manner that does not degrade the physical or chemical characteristics of the material. For example, as previously mentioned, one way the crystallinity of the polymeric material can be decreased is by heating it to a sufficient temperature to increase its amorphous content. For example, the polymeric material can be heated to about its melt point, or to a temperature above its melt point. While there is no intent to be limited to any particular mechanism, heating the polymeric material, e.g. to its melt point, or to a temperature above its melt point, increases the amorphous content of the polymeric material and thus decreases its crystallinity.
After heating the polymeric material to decrease its crystallinity, e.g. increase its amorphous phase, the polymeric material is cooled at a rate sufficient to lock it in a state of reduced crystallinity. For example, the polymeric material can be cooled to a temperature below its melt point to lock in the amorphous phase, and thereby decrease the crystallinity of the polymeric material. The cooling can be accomplished by any method or procedure which results in a cooling rate sufficient to cause an increase in the amorphous phase and thus accomplish a decrease in the crystallinity of the polymeric material. For example, the cooling rate can be in the range from about 1° C./minute to about 50° C./minute. Greater cooling rates are also contemplated. For example, cooling rates from about 100° C./minute to about 300° C./minute or even greater cooling rates can also be utilized. For example, any cooling rate can be utilized as long as the rate is sufficient to “lock” in at least a portion of the increase in the polymeric material's amorphous content, and thus maintain at least some of the decrease in the crystallinity of the polymeric material when returned to a temperature below its melt point.
The process for cooling the polymeric material can involve exposing the material to any number of cooling media such as liquid nitrogen, alcohol/dry ice, a cooled surface as previously mentioned, and cooled salt water. Cooling media may also include, for example, cooling at room temperature or cooling with elevated temperature liquids, gasses, or surfaces, i.e. liquids, gasses, or gasses that have an elevated temperature relative to room temperature, but have a temperature that is cooler than the temperature of the polymeric material being cooled.
After being cooled the polymeric material can be subjected to a crosslinking process. For example, exposing the polymeric material to radiation such as gamma radiation, electron beam, or X-rays causes the crosslinking of the polymeric material. As previously indicated such exposure may be in the exemplary range of from about 5 kGy to about 500 kGy, illustratively from about 25 kGy to about 100 kGy, and illustratively from about 30 kGy to about 60 kGy. As indicated above, a specific example of a crosslinked polymeric material that can be utilized in the construction of a device to be implanted in the body of an animal, such as the bearing component described herein, is crosslinked UHMWPE. For example, after decreasing the crystillinity of the UHMWPE as described above, it can be crosslinked by exposing it to radiation in the range of from about 25 kGy to about 100 kGy.
Once crosslinked, the polymeric material can be subjected to a post-irradiation free radical quenching process. For example, the free radical containing polymeric material can be melt annealed to quench the free radicals. For example, the free radical containing polymeric material can be placed into a vacuum oven under reduced pressure. To quench substantially all the free radicals present in the polymeric material, the temperature of the vacuum oven can then be raised to above the melting point of the polymeric material (e.g. greater than 135° C.) until it is completely melted. The polymeric material can then be kept at a temperature above its melt point for time period of about 24 hours. In any event, the polymeric material subjected to a post-irradiation free radical quenching process will be substantially free of free radicals.
Techniques for crosslinking, quenching, or otherwise preparing, for example, UHMWPE are described in numerous issued U.S. patents, examples of which include U.S. Pat. No. 5,728,748 (and its counterparts) issued to Sun, et al, U.S. Pat. No. 5,879,400 issued to Merrill et al, U.S. Pat. No. 6,017,975 issued to Saum, et al, U.S. Pat. No. 6,242,507 issued to Saum et al, U.S. Pat. No. 6,316,158 issued to Saum et al, U.S. Pat. No. 6,228,900 issued to Shen et al, U.S. Pat. No. 6,245,276 issued to McNulty et al, and U.S. Pat. No. 6,281,264 issued to Salovey et al. The disclosure of each of these U.S. patents is hereby incorporated by reference.
It should be appreciated that a polymeric material subjected to a treatment described herein can be utilized as a polymeric component of an implantable orthopaedic device, for example a bearing component of a knee, hip, shoulder, or elbow prostheses. Accordingly, the polymeric material can be subjected to a sterilization process, such as being gas plasma sterilized, prior to the orthopaedic device being implanted in the body of an animal.
Table 1 below lists the conventional steps for producing crosslinked UHMWPE for use in fabricating a device as compared to an example of a process for the crosslinking of a low crystallinity polymeric material for use in device fabrication.
Table 2 below shows the wear rate of disks subjected to a pin on disk wear test. Note that some of the polymeric material was subjected to a cooling procedure as discussed herein and thus have a reduced crystallinity, while others were tested without first decreasing their crystallinity. Note that each material referenced in Tables 2 and 3, i.e. GUR 1020, Hylamer (4150), and GUR 1050, are known examples of UHMWPE. Further note that all crystallinity values cited herein were determined by analyzing about 7.5 mg of the polymeric material with a TA Instruments Differential Scanning Calorimeter (DSC) model 2910 under a nitrogen atmosphere. The DSC method kept the sample of polymeric material isothermally at room temperature for 3 minutes, followed by a ramp to 180° C. at 10° C. per minute, followed by a cool-down cycle to 20° C.
The mechanical properties in Table 3 below indicate a slight loss of tensile strength and yield strength for the quick cooled samples, but no significant loss of elongation or impact strength.
As indicated above, decreasing the crystallinity of the UHMWPE sample prior to it being crosslinked with, for example, 60 kGy of radiation results in a polymeric material having an enhanced wear resistance as compared to a sample that was irradiation crosslinked without first decreasing its crystallinity. This is further illustrated in
While not wanting to be limited by any particular theory, it appears that crosslinking is more efficient when the polymeric material is in the amorphous phase as compared to the crystalline phase. Accordingly a lower dose of radiation can be utilized to crosslink this relatively amorphous polymeric material as compared to polymeric material in which the crystalline phase has not been reduced. Since a lower dose of radiation can be utilized to obtain an appropriate degree of crosslinking, the decreased irradiation of the polymeric material will still result in a lower wear rate while not adversely affecting the other mechanical properties of the material. Therefore, the crystallinity reduced polymeric material subjected to a relatively low dose of radiation will have (i) an enhanced wear rate as compared to a polymeric material in which the crystallinity is not reduced prior to being subjected to a relatively low dose of radiation and (ii) enhanced mechanical properties (e.g. properties that are important for the polymeric material to have when it is used in high stress designs) as compared to a polymeric material subjected to a relatively high dose of radiation.
The following examples demonstrate lowering the crystallinity so as to form a crystallinity gradient in a sample of polymeric material. In one embodiment, the crystallinity gradient is formed such that the crystallinity of the polymeric material is relatively low at, or near, an exterior surface of the material, but begins to increase moving in a direction away from the exterior surface of the material and toward the interior or central portion of the material. In other words, the crystallinity of the polymeric material begins to increase moving away from an external surface toward the interior or central portion of the material. Samples of polymeric material having a crystallinity gradient also has the same advantages as discussed above with respect to being able to utilize a relatively low dose of radiation for crosslinking. In addition, polymeric material having a crystallinity gradient have areas that are highly crystalline when irradiated. Accordingly, the mechanical properties in these areas are not adversely affected at all.
In particular,
Type T Teflon coated thermocouples from Omega Engineering (part number 5TC-TT-T-24-36) as well as a Type T, ungrounded, stainless steel sheathed thermocouple (part number TMQSS-032-U-6) were used. Using a one ml syringe and an 18-gauge needle, each hole was filled with type Z9 Silicone heat sink compound. The Teflon thermocouples were then wrapped with Teflon tape to increase their exterior diameter. This resulted in a snug fit when they were placed in the pucks. A fourth Teflon coated thermocouple was used externally to monitor the temperature of the cooling medium. For the third test which involved cooling the polymeric material in 100° C. boiling water and the second test which involved cooling the material in 50° C. water, the stainless steel sheathed thermocouple was used in place of the fourth Teflon-coated thermocouple. This was done to prevent the water from causing the thermocouple from shorting out.
For data acquisition, an IBM ThinkPad with a National Instruments DAQcard-6024E was used. LabView software was used for the user interface. Data was recorded at 10 hz using the software. The thermocouples were accurate to +/−five degrees Celsius.
An oven set to 165° C. with a constant flowing stream of Argon at four standard cubic feet per hour was used to heat each puck of polymeric material until it was clear. When the internal thermocouples read within three degrees of the external thermocouple, data logging was initiated and the puck was removed from the oven and placed directly into the cooling medium. As shown
For the samples cooled in water, data acquisition was terminated when the puck reached the temperature of the cooling water. In the case of the puck cooled in the oven, the oven was turned off and the puck was allowed to cool until the internal thermocouples read approximately 120° C. At that point, data acquisition was stopped and the puck was allowed to cool to room temperature in the oven. For the puck cooled in two ovens, the puck was removed from the first oven when clear, then held in the ambient air until the center thermocouple read 140° C., at which point it was placed into the 130° C. oven. The temperature of the 130° C. oven was monitored using a handheld meter and recorded every 5 minutes during the test. When all thermocouples read about 130° C., the part was removed and allowed to cool in the ambient air. Data acquisition was continued until the puck reached approximately 50° C. When all cooling experiments were complete a sample was taken out of the center of each puck measuring 7.6 mm×15.2 mm×the thickness of each puck (see
Cooling rates were calculated for each thermocouple by dividing the temperature change through the interval 140-130° C. by the time it took each thermocouple to pass through that range. This range was selected in order to determine the cooling rate at or slightly above the melt point, and definitely through the melt point. In order to pick the times for each thermocouple, time-temperature graphs were enlarged around the temperature range of 128-142° C. using Excel. Then, using the mouse, points were selected in the approximate middle of each temperature band at 140° C. and 130° C. and the time was read off. Cooling rate calculations are shown below in Table 5.
For comparison, the cooling rate for liquid nitrogen quenching is also included in Table 5 (CR-1-N). A comparison of cooling rates for the outermost thermocouple (3.8-4.5 mm), the second thermocouple (7.8-9.8 mm) and the center thermocouple (12.7-13.6 mm) are shown in
The crystallinity data from each group can be found in
Another observation is that it appears the surface of the puck crystallizes rapidly in the few seconds it takes to remove it from the oven and place it in the cooling media. In several tests (CR-RT, CR-50, CR-100) the crystallinity values for the samples taken from 200μ and 600 μm were similar in value, while the crystallinity value at 1000 μm was higher. Note that while care was taken to keep the puck in the ambient air as short of a time as possible, it appears that the crystallinity near the surface may have been established during the transition between the oven and the cooling media.
It is clear that utilizing a warmer cooling medium (e.g. warm water and hot water) resulted in the formation of a crystallinity gradient. However, it should be appreciated that a cold medium, such as liquid nitrogen, can also result in the formation of a crystallinity gradient. While there is no intent to be limited to any particular mechanism, it appears that the low thermal conductivity of polymeric materials, such as UHMWPE, produces a cooling gradient during the cooling process, which in turn also produces a crystallinity gradient in the material as discussed above. It should also be appreciated that the quicker one cools the polymeric material the greater the thickness of the low crystallinity region as measured from an exterior surface of the polymeric material to its interior or central portion. In other words, the quicker the polymeric material is cooled, the greater the proportion of the material is locked into the amorphous phase as opposed to the crystalline phase.
A polymeric material having a crystallinity gradient as described above can be subjected to a crosslinking process as previously discussed. In particular, the polymeric material having a crystallinity gradient can be crosslinked by exposing it to a medium or low dose of radiation. As discussed above, exposing the polymeric material having a crystallinity gradient to a medium or low dose of radiation results in the material having an enhanced wear rate while not adversely affecting the other mechanical properties of the material. In particular, subjecting a polymeric material having a crystallinity gradient to a medium or low dose of radiation will result in the material having (i) a lower wear rate as compared to a polymeric material in which the crystallinity is not reduced prior to being subjected to a relatively low dose of radiation, (ii) enhanced mechanical properties (e.g. properties that are important for the polymeric material to have when it is used in high stress designs) as compared to a polymeric material subjected to a relatively high dose of radiation, and (iii) the high crystallinity areas of the polymeric material have enhanced mechanical properties as compared to low crystallinity areas of the gradient.
As indicated above, the polymeric material having its crystallinity reduced, e.g. in the form of a crystallinity gradient, can be utilized as a component of an implantable orthopaedic device, for example a bearing component of a knee, hip, shoulder, or elbow prostheses. For example, the wear surface of the component having a relatively low crystallinity while the locking features (e.g. tabs) having a high crystallinity.
While the disclosure has been illustrated and described in detail in the foregoing description, such illustration and description is to be considered as exemplary and not restrictive in character, it being understood that only the preferred embodiments have been shown and described and that all changes and modifications that come within the spirit of the disclosure are desired to be protected.
| Number | Name | Date | Kind |
|---|---|---|---|
| 2948666 | Lawton | Aug 1960 | A |
| 3297641 | Werber et al. | Jan 1967 | A |
| 3352818 | Meyer et al. | Nov 1967 | A |
| 3646155 | Scott | Feb 1972 | A |
| 3671477 | Nesbitt | Jun 1972 | A |
| 3758273 | Johnston et al. | Sep 1973 | A |
| 3787900 | McGee | Jan 1974 | A |
| 3944536 | Lupton et al. | Mar 1976 | A |
| 3997512 | Casey et al. | Dec 1976 | A |
| 4055862 | Farling | Nov 1977 | A |
| 4138382 | Polmanteer | Feb 1979 | A |
| 4181983 | Kulkarni | Jan 1980 | A |
| 4195366 | Jarcho et al. | Apr 1980 | A |
| 4281420 | Raab | Aug 1981 | A |
| 4322398 | Reiner et al. | Mar 1982 | A |
| 4330514 | Nagai et al. | May 1982 | A |
| 4366618 | Lakes | Jan 1983 | A |
| 4373217 | Draenert | Feb 1983 | A |
| 4390666 | Moriguchi | Jun 1983 | A |
| 4452973 | Casey et al. | Jun 1984 | A |
| 4481353 | Nyilas et al. | Nov 1984 | A |
| 4483333 | Wartman | Nov 1984 | A |
| 4518552 | Matsuo et al. | May 1985 | A |
| 4539374 | Fenton et al. | Sep 1985 | A |
| 4563489 | Urist | Jan 1986 | A |
| 4578384 | Hollinger | Mar 1986 | A |
| 4582656 | Hoffmann | Apr 1986 | A |
| 4586995 | Randall et al. | May 1986 | A |
| 4637931 | Schmitz | Jan 1987 | A |
| 4655769 | Zachariades | Apr 1987 | A |
| 4668527 | Fujita et al. | May 1987 | A |
| 4743493 | Sioshansi et al. | May 1988 | A |
| 4747990 | Gaussens et al. | May 1988 | A |
| 4816517 | Wilkus | Mar 1989 | A |
| 4843112 | Gerhart et al. | Jun 1989 | A |
| 4876049 | Aoyama et al. | Oct 1989 | A |
| 4880610 | Constantz | Nov 1989 | A |
| 4888369 | Moore, Jr. | Dec 1989 | A |
| 4902460 | Yagi | Feb 1990 | A |
| 4944974 | Zachariades | Jul 1990 | A |
| 5001206 | Bashir et al. | Mar 1991 | A |
| 5014494 | George | May 1991 | A |
| 5024670 | Smith et al. | Jun 1991 | A |
| 5037928 | Li et al. | Aug 1991 | A |
| 5053312 | Takeda | Oct 1991 | A |
| 5084051 | Tormala et al. | Jan 1992 | A |
| 5085861 | Gerhart et al. | Feb 1992 | A |
| 5130376 | Shih | Jul 1992 | A |
| 5133757 | Sioshansi et al. | Jul 1992 | A |
| 5137688 | DeRudder | Aug 1992 | A |
| 5149368 | Liu et al. | Sep 1992 | A |
| 5153039 | Porter et al. | Oct 1992 | A |
| 5160464 | Ward et al. | Nov 1992 | A |
| 5160472 | Zachariades | Nov 1992 | A |
| 5180394 | Davidson | Jan 1993 | A |
| 5192323 | Shetty et al. | Mar 1993 | A |
| 5200439 | Asanuma | Apr 1993 | A |
| 5210130 | Howard, Jr. | May 1993 | A |
| 5236563 | Loh | Aug 1993 | A |
| 5264214 | Rhee et al. | Nov 1993 | A |
| 5314478 | Oka et al. | May 1994 | A |
| 5356998 | Hobes | Oct 1994 | A |
| 5385887 | Yim et al. | Jan 1995 | A |
| 5407623 | Zachariades et al. | Apr 1995 | A |
| 5414049 | Sun et al. | May 1995 | A |
| 5439949 | Lucas et al. | Aug 1995 | A |
| 5449745 | Sun et al. | Sep 1995 | A |
| 5466530 | England et al. | Nov 1995 | A |
| 5478906 | Howard, Jr. | Dec 1995 | A |
| 5480683 | Chabrol et al. | Jan 1996 | A |
| 5492697 | Boyan et al. | Feb 1996 | A |
| 5508319 | DeNicola | Apr 1996 | A |
| 5515590 | Pienkowski | May 1996 | A |
| 5543471 | Sun et al. | Aug 1996 | A |
| 5549698 | Averill et al. | Aug 1996 | A |
| 5549700 | Graham et al. | Aug 1996 | A |
| 5577368 | Hamilton et al. | Nov 1996 | A |
| 5593719 | Deamaley et al. | Jan 1997 | A |
| 5607518 | Hoffman et al. | Mar 1997 | A |
| 5609638 | Price et al. | Mar 1997 | A |
| 5639280 | Warner et al. | Jun 1997 | A |
| 5645594 | Devanathan et al. | Jul 1997 | A |
| 5645882 | Llanos | Jul 1997 | A |
| 5650485 | Sun et al. | Jul 1997 | A |
| 5674293 | Armini et al. | Oct 1997 | A |
| 5684124 | Howard, Jr. et al. | Nov 1997 | A |
| 5702448 | Buechel et al. | Dec 1997 | A |
| 5702456 | Pienkowski | Dec 1997 | A |
| 5709020 | Pienkowski et al. | Jan 1998 | A |
| 5728748 | Sun et al. | Mar 1998 | A |
| 5753182 | Higgins | May 1998 | A |
| 5876453 | Beaty | Mar 1999 | A |
| 5879388 | Pienkowski et al. | Mar 1999 | A |
| 5879400 | Merrill et al. | Mar 1999 | A |
| 5879407 | Waggener | Mar 1999 | A |
| 5947893 | Agrawal et al. | Sep 1999 | A |
| 6005053 | Parikh et al. | Dec 1999 | A |
| 6017975 | Saum et al. | Jan 2000 | A |
| 6027742 | Lee et al. | Feb 2000 | A |
| 6087553 | Cohen et al. | Jul 2000 | A |
| 6136029 | Johnson et al. | Oct 2000 | A |
| 6139322 | Liu | Oct 2000 | A |
| 6139585 | Li | Oct 2000 | A |
| 6143232 | Rohr | Nov 2000 | A |
| 6162225 | Gertzman et al. | Dec 2000 | A |
| 6168626 | Hyon et al. | Jan 2001 | B1 |
| 6228900 | Shen et al. | May 2001 | B1 |
| 6242507 | Saum et al. | Jun 2001 | B1 |
| 6245276 | McNulty et al. | Jun 2001 | B1 |
| 6281262 | Shikinami | Aug 2001 | B1 |
| 6281264 | Salovey et al. | Aug 2001 | B1 |
| 6296667 | Johnson et al. | Oct 2001 | B1 |
| 6302913 | Ripamonti et al. | Oct 2001 | B1 |
| 6316158 | Saum et al. | Nov 2001 | B1 |
| 6331312 | Lee et al. | Dec 2001 | B1 |
| 6376573 | White et al. | Apr 2002 | B1 |
| 6464926 | Merrill et al. | Oct 2002 | B1 |
| 6626324 | Boyd | Sep 2003 | B1 |
| 20010027345 | Merrill et al. | Oct 2001 | A1 |
| 20020006428 | Mahmood et al. | Jan 2002 | A1 |
| 20070191504 | Muratoglu | Aug 2007 | A1 |
| Number | Date | Country |
|---|---|---|
| BE-A-1001574 | Dec 1989 | BE |
| 196 10715 | Jun 1997 | DE |
| 0 169 259 | Jul 1984 | EP |
| 0 373 800 | Jun 1990 | EP |
| 0 395 187 | Oct 1990 | EP |
| 0 505 634 | Sep 1992 | EP |
| 0722973 | Jul 1996 | EP |
| 0729981 | Sep 1996 | EP |
| 0 737481 | Oct 1996 | EP |
| 0 803 234 | Oct 1997 | EP |
| 0 963 824 | Dec 1999 | EP |
| 0 963 824 | Sep 2001 | EP |
| 1 208 958 | May 2002 | EP |
| 1 277 450 | Jan 2003 | EP |
| 58-157830 | Sep 1983 | JP |
| A-59 168 050 | Sep 1984 | JP |
| A-62 243 634 | Jan 1987 | JP |
| 04-198242 | Jul 1992 | JP |
| A-04 185651 | Jul 1992 | JP |
| 09 12 22 22 | May 1997 | JP |
| WO 9310953 | Nov 1991 | WO |
| WO 9521212 | Aug 1995 | WO |
| WO 9609330 | Mar 1996 | WO |
| WO 9729793 | Aug 1997 | WO |
| WO 9801085 | Jan 1998 | WO |
| WO 9814223 | Apr 1998 | WO |
| WO 9829145 | Jul 1998 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 20060004168 A1 | Jan 2006 | US |
